Analysis of T1c prostate cancers treated at very low prostate-specific antigen levels
Wednesday, 13 August 2008 - The Prostate Cancer Prevention Trial (PCPT) has challenged the validity of recommended prostate-specific antigen (PSA) thresholds for prostate biopsy (>2.5ng/ml) given the 17% prostate cancer (pCA) detection rate at PSA of 1.1-2.0. The outcome of patients treated at PSA < /=2.5 is...
Authors: Stephenson et al.
Diagnostic accuracy of extended biopsies for the staging of microfocal prostate cancers in autopsy specimen
Thursday, 7 August 2008 - Clinically insignificant prostate cancers may be predicted when biopsies show a microfocal cancer (MiFC). However, at least one-third of MiFC are underestimated by biopsies. Delongchamps et al. (2008) evaluated the staging accuracy of different biopsy regimen showing a MiFC.
The authors...
Authors: Delongchamps et al.
Imaging of urinary tract tumors
Wednesday, 6 August 2008 - Imaging has an important role in the evaluation of patients with invasive bladder cancer. It is useful in staging of bladder cancer, despite having some limitations. Computed tomography (CT) is widely accessible and has enjoyed rapid advances in multidetector technology with far-reaching...
Source: Springer
Doxorubicin and epirubicin for the treatment of patients with metastatic hormone-refractory prostate cancer
Monday, 4 August 2008 - Advanced hormone-refractory prostate cancer (HRPC) is characterized by prevalently osteoblastic bone metastases that mostly affect these patients' quality of life and make the assessment of response to treatment particularly difficult by commonly used criteria. HRPC cannot be cured by any...
Authors: Petrioli et al.
Vitamin D and intervention trials in prostate cancer: from theory to therapy
Monday, 4 August 2008 - Studies of vitamin D and prostate cancer have advanced rapidly from the hypothesis that vitamin D deficiency increases the risk of prostate cancer to intervention trials of vitamin D administration in clinical cancer. Schwartz (2008) discussed vitamin D and intervention trials in prostate...
Author: Schwartz
Pathologic T2 stage subgroups and recurrence-free survival after radical prostatectomy
Thursday, 31 July 2008 - Decastro et al. (2008) determined whether present subclassifications for pathologic T2 (pT2) prostate cancer were predictive for recurrence-free survival (RFS) after radical prostatectomy.
The study sample included 906 patients who underwent radical prostatectomy between 1990 and 2004 and...
Authors: Decastro et al.
Loss and progressive recovery of voiding after spinal cord interruption in animal model
Monday, 28 July 2008 - Autonomous contractile activity (ACA) is a well-known phenomenon in isolated bladders from different species and seems to be important in the physiology of both normal and dysfunctional voiding. Gevaert et al. (2008) determined whether ACA is changed in bladders from paraplegic rats at different...
Authors: Gevaert et al.
Large studies needed to further confirm prostate cancer drug abiraterone
Wednesday, 22 July 2008- Larger trials are needed to further examine and confirm the early findings on the experimental drug abiraterone acetate (CB7630). Researcher Dr. Johann de Bono, from the Institute of Cancer Research and the Royal Marsden NHS Foundation Trust in the UK, who led two ongoing clinical trials...
By Joel Vega
Satisfaction and regret after ppen retropubic or robot-assisted laparoscopic radical prostatectomy
Wednesday, 23 July 2008 - To counsel patients adequately, it is important to understand the variables influencing satisfaction and regret following prostatectomy. Schroeck et al. (2008) identified independent predictors for satisfaction and regret after radical prostatectomy.
Patients who had undergone retropubic...
Authors: Schroeck et al.
New, informative EAU website launched: www.urologyweek.org
Friday, 18 July 2008 - The European Association of Urology (EAU) launched a new website recently as platform for the promotional activities for the first European Urology Week, which will be organised from 15 to 19 September. www.urologyweek.org is a general publicoriented site which should provide people with...
By: Lindy Brouwer
